Purpose: To evaluate the display quality of digital radiographies on different monitors in comparison to hard-copy films on view boxes.
Materials And Methods: Radiographs of different statistical phantoms simulating common pathologies of the chest, such as interstitial pneumonia, pneumothorax and pulmonary nodules, were acquired. Under same ambient light condition, the radiographs were rated as to the presence or absence of a simulated pathological finding using a confidence scale. The evaluation was performed on a grey-scale monitor, a color monitor, two LC displays and two different light boxes by four experienced radiologists. Sensitivity and specificity were determined in a ROC analysis for each viewing modality and phantom. The area under the curve (Az) was acquired cumulatively including the results of all investigators. A total of 4200 rating decisions were included. The chi (2)-test was performed for significance analysis using the a and b parameters of two ROC-curves (alpha = 0.05).
Results: The rating of the included LC displays (Az = 0.7009 - 0.9608) and color monitors (Az = 0.7993 - 0.9591) showed a significant loss of diagnostic validity in comparison to the grey-scale monitor (Az = 0.8435 - 0.9762) and the view boxes (Az = 0.8228 - 0.9891).
Conclusion: LC displays and color monitor included in this study cannot be recommended for diagnostic viewing. The loss of diagnostic validity might be attributable to the viewing-angle-dependent contrast of LC displays. However, no loss in diagnostic validity could be assessed for the tested grey-scale monitor.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/s-2004-813200 | DOI Listing |
J Ophthalmol
October 2024
Specialty Eye Hospital Svjetlost, School of Medicine, University of Rijeka, Zagreb, Croatia.
To determine if cross-linking (CXL) treatment modifies any pre-existing association between corneal optical density (COD) and age in keratoconus free of corneal scarring. COD was monitored in two groups (i) before and after standard CXL treatment for keratoconus (de-epithelization with a crescent blade, = 69 eyes) and (ii) age/gender-matched cases without any signs of keratoconus ( = 24 eyes). Seven different markers of COD were quantified using a 0-100 grey scale, supplied with Pentacam™ software.
View Article and Find Full Text PDFPLoS One
September 2024
Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Science, Suzhou, China.
Ophthalmol Ther
October 2024
Department of Cataract and Refractive Surgery, University Eye Hospital Svjetlost, 10000, Zagreb, Croatia.
Introduction: Objective markers describing corneal optical density (COD), thinnest corneal thickness (TCT), and anterior (ARC) and posterior (PRC) surface radii over the 3 mm thinnest region of the cornea were investigated to provide a model for estimating corrected distance visual acuity (CDVA) after corneal cross-linking (CXL) in keratoconus.
Methods: CDVA, COD, TCT, ARC, and PRC were monitored (using Pentacam™) over 1 year in patients with (1) keratoconus treated with routine CXL (2) relatively stable untreated keratoconus, and (3) age/gender-matched controls.
Results: In group 1 (n = 77), the median logMAR CDVA (mode, interquartile range) improved significantly (p < 0.
Med Phys
October 2024
Henan Provincial Key Laboratory of Intelligent Manufacturing of Mechanical Equipment, Henan International Joint Laboratory of Complex Mechanical Equipment Intelligent Monitoring and Control, Zhengzhou University of Light Industry, Zhengzhou, China.
Lancet Rheumatol
February 2024
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK. Electronic address:
Background: Subclinical synovitis occurs in a third of individuals at risk of rheumatoid arthritis. The objective of this study was to assess the reversibility of subclinical synovitis in individuals at risk of rheumatoid arthritis who are positive for anti-cyclic citrullinated peptide (CCP) antibody with musculoskeletal symptoms and investigate factors associated with its resolution within 12 months.
Methods: We conducted a single-centre, prospective, cohort study in the UK, recruiting individuals aged 18 years or older who were anti-CCP-positive with a new non-specific musculoskeletal symptom but no clinical synovitis.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!